1 completed, 1 recruiting, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow pCAR-19B cells: new trials by email Literature Review of pCAR-19B cells trials Research Report on pCAR-19B cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents pCAR-19B cells - Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL | Phase 2 | Recruiting | Chongqing Precision Biotech Co., Ltd | 100 | 2022-01-26 | 2026-09-15 |
| Phase I Study of pCAR-19B in the Treatment of Adult CD19-positive Relapsed/Refractory B-ALL pCAR-19B cells - Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia | Phase 1 | Unknown | Chongqing Precision Biotech Co., Ltd | 18 | 2020-10-26 | 2021-05-17 |
| Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents pCAR-19B cells - Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL | Phase 1 | Completed | Chongqing Precision Biotech Co., Ltd | 9 | 2019-11-05 | 2022-03-18 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)
Chongqing Precision Biotech Co., Ltd (3)
China (3)
Jianfeng Zhou, M.D. Ph.D (2) · Tianyou Wang, M.D. Ph.D (1) · Yicheng Zhang, M.D. Ph.D (1)